Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy - Related Studies

Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy

This study is ongoing, but not recruiting participants.

Study NCT00004407. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetic Neuropathies

2	More general conditions related to this trial
		Diabetes Complications
		Diabetes Mellitus
		Endocrine System Diseases
		Nervous System Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases

3	Interventions listed in this trial
		immune globulin

4	Additional drug interventions recognized in this trial
		Immunoglobulins
		Immunoglobulins, Intravenous

5	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		Mayo Clinic